US Stock MarketDetailed Quotes

ESPR Esperion Therapeutics

Watchlist
  • 2.190
  • +0.015+0.69%
Close Dec 20 16:00 ET
  • 2.180
  • -0.010-0.45%
Post 19:56 ET
431.51MMarket Cap-3.27P/E (TTM)

Esperion Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-82.79%-35.33M
70.89%-7.21M
199.03%53.83M
22.50%-135.49M
12.75%-37.06M
54.88%-19.33M
51.02%-24.75M
-39.41%-54.36M
33.73%-174.83M
26.40%-42.47M
Net income from continuing operations
28.43%-29.52M
-24.01%-61.93M
198.87%61.02M
10.45%-209.25M
-1.54%-56.34M
25.16%-41.25M
24.71%-49.94M
-8.79%-61.72M
13.17%-233.66M
14.79%-55.49M
Operating gains losses
--0
----
----
----
----
----
----
----
----
----
Depreciation and amortization
0.00%26K
-80.39%10K
--0
-67.20%164K
-93.48%6K
-75.24%26K
-66.00%51K
-47.06%81K
-18.30%500K
-39.87%92K
Other non cash items
-71.07%3.57M
-70.19%3.54M
-3.09%11.37M
4.69%48.38M
6.22%12.41M
7.33%12.35M
2.34%11.89M
2.84%11.74M
30.07%46.21M
6.15%11.68M
Change In working capital
-288.78%-12.42M
-149.20%-5M
-210.63%-21.8M
505.43%13.68M
278.72%3.96M
317.34%6.58M
3,275.42%10.16M
-548.21%-7.02M
93.58%-3.37M
60.37%-2.21M
-Change in receivables
-309.21%-7.46M
-31.11%-5.75M
-127.77%-6.12M
-36.78%-14.77M
-162.10%-5.87M
49.96%-1.82M
-60.70%-4.38M
-23.10%-2.69M
-2.36%-10.8M
-83.01%-2.24M
-Change in inventory
175.83%4.37M
-79.85%-11.37M
-80.00%-7.47M
-3,669.76%-30.42M
-150.85%-14.19M
-1,739.94%-5.76M
-198.47%-6.32M
-229.44%-4.15M
95.58%-807K
-1,240.28%-5.66M
-Change in prepaid assets
-82.61%-3.94M
-94.08%315K
-309.83%-6.59M
336.36%6.19M
794.98%4.64M
-16.35%-2.16M
167.34%5.32M
-310.47%-1.61M
1,333.33%1.42M
151.96%518K
-Change in payables and accrued expense
-98.30%208K
69.71%20.49M
22.88%-5.57M
219.91%30.78M
140.21%13.7M
207.42%12.23M
288.46%12.07M
-213.87%-7.22M
135.40%9.62M
240.64%5.7M
-Change in other working capital
-236.81%-5.59M
-349.58%-8.68M
-54.36%3.95M
879.18%21.9M
1,155.58%5.68M
442.46%4.09M
240.22%3.48M
511.90%8.65M
-160.37%-2.81M
-122.38%-538K
Cash from discontinued investing activities
Operating cash flow
-82.79%-35.33M
70.89%-7.21M
199.03%53.83M
22.50%-135.49M
12.75%-37.06M
54.88%-19.33M
51.02%-24.75M
-39.41%-54.36M
33.73%-174.83M
26.40%-42.47M
Investing cash flow
Cash flow from continuing investing activities
-167K
-100.44%-77K
-100.29%-73K
424.43%42.5M
0
0
250.00%17.5M
238.11%25M
116.05%8.1M
76.64%-11.79M
Net PPE purchase and sale
---167K
---77K
---73K
----
----
--0
--0
--0
----
----
Net investment purchase and sale
--0
--0
--0
424.43%42.5M
--0
--0
250.00%17.5M
238.11%25M
116.05%8.1M
76.64%-11.79M
Cash from discontinued investing activities
Investing cash flow
---167K
-100.44%-77K
-100.29%-73K
424.43%42.5M
--0
--0
250.00%17.5M
238.11%25M
116.05%8.1M
76.64%-11.79M
Financing cash flow
Cash flow from continuing financing activities
-110.92%-9.1M
-3,811.12%-30.02M
83.07%90.61M
54.76%50.46M
114.73%4.47M
-109.31%-4.31M
-95.53%809K
3,546.52%49.49M
-87.84%32.61M
-114.23%-30.36M
Net common stock issuance
1,812.90%531K
--0
72.39%90.67M
-37.40%56.88M
--0
-100.06%-31K
-78.68%4.31M
--52.6M
-58.46%90.85M
-89.74%21.99M
Cash dividends paid
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Proceeds from stock option exercised by employees
--0
90,610.00%9.07M
--5.77M
--9.09M
--9.07M
--11K
--10K
--0
--0
--0
Net other financing activities
---9.63M
----
----
----
----
----
----
----
-201.24%-50.22M
-40,100.00%-50M
Cash from discontinued financing activities
Financing cash flow
-110.92%-9.1M
-3,811.12%-30.02M
83.07%90.61M
54.76%50.46M
114.73%4.47M
-109.31%-4.31M
-95.53%809K
3,546.52%49.49M
-87.84%32.61M
-114.23%-30.36M
Net cash flow
Beginning cash position
36.71%189.3M
56.38%226.61M
-34.08%82.25M
-51.80%124.78M
-45.16%114.83M
-19.93%138.47M
-27.68%144.91M
-51.80%124.78M
-15.11%258.89M
36.26%209.4M
Current changes in cash
-88.63%-44.59M
-479.18%-37.31M
616.93%144.36M
68.29%-42.53M
61.49%-32.59M
-164.83%-23.64M
76.51%-6.44M
134.40%20.14M
-191.12%-134.12M
-180.43%-84.62M
End cash Position
26.02%144.72M
36.71%189.3M
56.38%226.61M
-34.08%82.25M
-34.08%82.25M
-45.16%114.83M
-19.93%138.47M
-27.68%144.91M
-51.80%124.78M
-51.80%124.78M
Free cash flow
-83.66%-35.49M
70.58%-7.28M
198.89%53.76M
22.50%-135.49M
12.75%-37.06M
54.88%-19.33M
51.02%-24.75M
-39.41%-54.36M
33.73%-174.83M
26.40%-42.47M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -82.79%-35.33M70.89%-7.21M199.03%53.83M22.50%-135.49M12.75%-37.06M54.88%-19.33M51.02%-24.75M-39.41%-54.36M33.73%-174.83M26.40%-42.47M
Net income from continuing operations 28.43%-29.52M-24.01%-61.93M198.87%61.02M10.45%-209.25M-1.54%-56.34M25.16%-41.25M24.71%-49.94M-8.79%-61.72M13.17%-233.66M14.79%-55.49M
Operating gains losses --0------------------------------------
Depreciation and amortization 0.00%26K-80.39%10K--0-67.20%164K-93.48%6K-75.24%26K-66.00%51K-47.06%81K-18.30%500K-39.87%92K
Other non cash items -71.07%3.57M-70.19%3.54M-3.09%11.37M4.69%48.38M6.22%12.41M7.33%12.35M2.34%11.89M2.84%11.74M30.07%46.21M6.15%11.68M
Change In working capital -288.78%-12.42M-149.20%-5M-210.63%-21.8M505.43%13.68M278.72%3.96M317.34%6.58M3,275.42%10.16M-548.21%-7.02M93.58%-3.37M60.37%-2.21M
-Change in receivables -309.21%-7.46M-31.11%-5.75M-127.77%-6.12M-36.78%-14.77M-162.10%-5.87M49.96%-1.82M-60.70%-4.38M-23.10%-2.69M-2.36%-10.8M-83.01%-2.24M
-Change in inventory 175.83%4.37M-79.85%-11.37M-80.00%-7.47M-3,669.76%-30.42M-150.85%-14.19M-1,739.94%-5.76M-198.47%-6.32M-229.44%-4.15M95.58%-807K-1,240.28%-5.66M
-Change in prepaid assets -82.61%-3.94M-94.08%315K-309.83%-6.59M336.36%6.19M794.98%4.64M-16.35%-2.16M167.34%5.32M-310.47%-1.61M1,333.33%1.42M151.96%518K
-Change in payables and accrued expense -98.30%208K69.71%20.49M22.88%-5.57M219.91%30.78M140.21%13.7M207.42%12.23M288.46%12.07M-213.87%-7.22M135.40%9.62M240.64%5.7M
-Change in other working capital -236.81%-5.59M-349.58%-8.68M-54.36%3.95M879.18%21.9M1,155.58%5.68M442.46%4.09M240.22%3.48M511.90%8.65M-160.37%-2.81M-122.38%-538K
Cash from discontinued investing activities
Operating cash flow -82.79%-35.33M70.89%-7.21M199.03%53.83M22.50%-135.49M12.75%-37.06M54.88%-19.33M51.02%-24.75M-39.41%-54.36M33.73%-174.83M26.40%-42.47M
Investing cash flow
Cash flow from continuing investing activities -167K-100.44%-77K-100.29%-73K424.43%42.5M00250.00%17.5M238.11%25M116.05%8.1M76.64%-11.79M
Net PPE purchase and sale ---167K---77K---73K----------0--0--0--------
Net investment purchase and sale --0--0--0424.43%42.5M--0--0250.00%17.5M238.11%25M116.05%8.1M76.64%-11.79M
Cash from discontinued investing activities
Investing cash flow ---167K-100.44%-77K-100.29%-73K424.43%42.5M--0--0250.00%17.5M238.11%25M116.05%8.1M76.64%-11.79M
Financing cash flow
Cash flow from continuing financing activities -110.92%-9.1M-3,811.12%-30.02M83.07%90.61M54.76%50.46M114.73%4.47M-109.31%-4.31M-95.53%809K3,546.52%49.49M-87.84%32.61M-114.23%-30.36M
Net common stock issuance 1,812.90%531K--072.39%90.67M-37.40%56.88M--0-100.06%-31K-78.68%4.31M--52.6M-58.46%90.85M-89.74%21.99M
Cash dividends paid --0--0--0--0--0--0--0--0--0--0
Proceeds from stock option exercised by employees --090,610.00%9.07M--5.77M--9.09M--9.07M--11K--10K--0--0--0
Net other financing activities ---9.63M-----------------------------201.24%-50.22M-40,100.00%-50M
Cash from discontinued financing activities
Financing cash flow -110.92%-9.1M-3,811.12%-30.02M83.07%90.61M54.76%50.46M114.73%4.47M-109.31%-4.31M-95.53%809K3,546.52%49.49M-87.84%32.61M-114.23%-30.36M
Net cash flow
Beginning cash position 36.71%189.3M56.38%226.61M-34.08%82.25M-51.80%124.78M-45.16%114.83M-19.93%138.47M-27.68%144.91M-51.80%124.78M-15.11%258.89M36.26%209.4M
Current changes in cash -88.63%-44.59M-479.18%-37.31M616.93%144.36M68.29%-42.53M61.49%-32.59M-164.83%-23.64M76.51%-6.44M134.40%20.14M-191.12%-134.12M-180.43%-84.62M
End cash Position 26.02%144.72M36.71%189.3M56.38%226.61M-34.08%82.25M-34.08%82.25M-45.16%114.83M-19.93%138.47M-27.68%144.91M-51.80%124.78M-51.80%124.78M
Free cash flow -83.66%-35.49M70.58%-7.28M198.89%53.76M22.50%-135.49M12.75%-37.06M54.88%-19.33M51.02%-24.75M-39.41%-54.36M33.73%-174.83M26.40%-42.47M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Heat List
US
Overall
Symbol
Price
% Chg

No Data